Immunogenicity and safety of the non-typable Haemophilus influenzae- Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trialClinical Trial Published on 2023-12-312023-06-01 Journal: Human vaccines & immunotherapeutics [Category] 두창, 수두, 홍역, [키워드] Adjuvant system AS01 chronic obstructive pulmonary disease immune response Moraxella catarrhalis non-inferiority non-typable Haemophilus influenzae Recombinant zoster vaccine. [DOI] 10.1080/21645515.2023.2187194 PMC 바로가기 [Article Type] Clinical Trial